Recent research suggests that these peptides may effectively mitigate the risk of obesity and the onset of type-2 diabetes by suppressing the enzyme dipeptidyl peptidase-IV (DPP-IV), which is present in various organs, including the kidney and the gut. The gene discussed is DPP4; the disease is Obesity.